[Bioregulatory functions of methylsphingosines: in relation to sphingolipid signaling pathway and on approach of introducing sphingolipid-based drugs].
Igarashi
Y
Y
Department of Pathobiology, University of Washington, Seattle, USA.
D017209:Apoptosis; D002455:Cell Division; D002462:Cell Membrane / Q000378:metabolism; D006860:Hydrogen Bonding; D007249:Inflammation / Q000188:drug therapy; D009362:Neoplasm Metastasis / Q000517:prevention & control; D009369:Neoplasms / Q000473:pathology; D015539:Platelet Activation / Q000187:drug effects; D011493:Protein Kinase C / Q000037:antagonists & inhibitors; D015427:Reperfusion Injury / Q000517:prevention & control; D015398:Signal Transduction; D013107:Sphingolipids / Q000378:metabolism*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000502:physiology / Q000627:therapeutic use
D013107:Sphingolipids; C071600:N,N,N-trimethylsphingosine; D011493:Protein Kinase C; C061800:N,N-dimethylsphingosine; D013110:Sphingosine